Chronic Cough Market Trends, Surging Demand, Detailed Analysis, And Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Chronic Cough Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $11.48 billion In 2028 At A CAGR Of 8.9%.

The chronic cough market size has grown strongly in recent years. It will grow from $7.5 billion in 2023 to $8.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to prevalence of underlying respiratory conditions, environmental factors and air pollution, smoking and tobacco use, respiratory infections, allergies and environmental sensitivities.

The chronic cough market size is expected to see strong growth in the next few years. It will grow to $11.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

Chronic Cough Market Major Segments
The chronic cough market covered in this report is segmented -

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Key Driver - Surging Prevalence Of Cough Sparks Momentum In The Chronic Cough Market

The rise in the prevalence of cough is expected to propel the growth of the chronic cough market going forward. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries. Furthermore, in March 2022, according to the Statens Serum Institut, a Denmark-based department of disease surveillance, the number of pertussis cases recorded increased by 41% from November 2022 to April 2023, compared to November 2021-April 2022 in Denmark. Therefore, the rise in the prevalence of cough is driving the growth of the chronic cough market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12109&type=smp

Prominent Trend - Innovative Product Developments Transforming The Landscape Of The Chronic Cough Market

Major companies operating in the chronic cough market are concentrating on creating innovative products such as cough syrup to strengthen their position in the market. Cough syrup is used to treat upper respiratory allergies and common cold which contain non-opioid cough suppressants that acts on the cough center, a specific area of the brain, to assist stop coughing. For instance, in September 2021, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company launched Chericof 12. Chericof 12 is a new cough remedy formulation and the first prescription cough syrup that offers 12-hour relief. Chericof 12 is produced with the use of Polistirex technology, which provides a longer-lasting medication release and helps to improve patient compliance by preventing dosage modifications. Using Polistirex technology, the formulation complexes two medications, chlorpheniramine maleate and dextromethorphan hydrobromide. As a result, the medication is released gradually, helping to relieve coughing for an extended period of time.

Chronic Cough Market Players
Major companies operating in the chronic cough market report are Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Glaxo SmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the chronic cough market in 2023. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Chronic Cough Market Report Structure
3. Chronic Cough Market Trends And Strategies
4. Chronic Cough Market - Macro Economic Scenario
5. Chronic Cough Market Size And Growth
…..
27. Chronic Cough Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.